Neodymium

DB15318ExperimentalSmall molecule

Neodymium is under investigation in clinical trial NCT03525522 (Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus).

Chemical structure of Neodymium
Formula / weight
Nd · 144.242 g/mol (avg)

Resolves to

Compound
UNII2I87U3734ACAS7440-00-8ChEBI33372
Clinical / RWD
RxNorm1311480
Structure
InChIKeyQEFYFXOXNSNQGX-UHFFFAOYSA-NSMILES[Nd]
Targets
O43497CACNA1G

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Neodymium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In